SunLink Health Systems Inc Asset Resilience Ratio
SunLink Health Systems Inc asset resilience ratio. SunLink Health Systems Inc (SSY) has an Asset Resilience Ratio of 42.73% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SSY defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of SunLink Health Systems Inc (2012–2024)
Asset resilience ratio of SunLink Health Systems Inc from 2012 to 2024. This chart shows how SunLink Health Systems Inc's Asset Resilience Ratio has changed over time. Read SunLink Health Systems Inc debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down SunLink Health Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SSY current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $7.47 Million | 42.73% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $7.47 Million | 42.73% |
Asset Resilience Insights
- Very High Liquidity: SunLink Health Systems Inc maintains exceptional liquid asset reserves at 42.73% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
SunLink Health Systems Inc Industry Peers by Asset Resilience Ratio
Compare SunLink Health Systems Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Yunnan Hongxiang Yixintang
SHE:002727 |
Pharmaceutical Retailers | 6.05% |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017 |
Pharmaceutical Retailers | 0.01% |
|
Cachet Pharmaceutical Co Ltd
SHE:002462 |
Pharmaceutical Retailers | 0.00% |
|
High Tide Inc
V:HITI |
Pharmaceutical Retailers | 0.02% |
|
Raia Drogasil S.A
SA:RADL3 |
Pharmaceutical Retailers | 0.46% |
|
Empreendimentos Pague Menos S.A
SA:PGMN3 |
Pharmaceutical Retailers | 0.00% |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3 |
Pharmaceutical Retailers | 2.05% |
|
Yifeng Pharmacy
SHG:603939 |
Pharmaceutical Retailers | 19.16% |
SunLink Health Systems Inc Asset Resilience Ratio by Year (2012–2024)
SunLink Health Systems Inc asset resilience ratio by year from 2012 to 2024. The table below shows the annual Asset Resilience Ratio data for SunLink Health Systems Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 34.79% | $7.17 Million | $20.61 Million | +15.51pp |
| 2023-06-30 | 19.28% | $4.49 Million | $23.27 Million | -12.28pp |
| 2021-06-30 | 31.56% | $9.96 Million | $31.56 Million | -8.42pp |
| 2020-06-30 | 39.98% | $11.18 Million | $27.97 Million | +8.28pp |
| 2019-06-30 | 31.70% | $7.74 Million | $24.42 Million | +18.50pp |
| 2018-06-30 | 13.20% | $3.46 Million | $26.18 Million | -21.32pp |
| 2017-06-30 | 34.52% | $12.20 Million | $35.34 Million | +27.25pp |
| 2016-06-30 | 7.27% | $3.26 Million | $44.84 Million | -- |
| 2015-06-30 | 0.00% | $0.00 | $57.13 Million | -- |
| 2014-06-30 | 0.00% | $0.00 | $63.85 Million | -- |
| 2013-06-30 | 0.24% | $160.00K | $68.00 Million | -- |
| 2012-06-30 | 0.00% | $0.00 | $79.17 Million | -- |
About SunLink Health Systems Inc
As of August 14, 2025, SunLink Health Systems, Inc. was acquired by Regional Health Properties, Inc. SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. The company operates through Healthcare Services and Pharmacy segments. It is also involved in provision of specialty and non-specialty pharmaceutical and biological… Read more